Bone resorptive cytokines, including interleukin 1 (IL-1) and tumor necrosis factor (TNF), have been implicated in the bone destruction associated with periodontitis, arthritis, osteoporosis and the hypercalcemia of malignancy. These mediators concomitantly inhibit bone formation through negative effects regulation of matrix protein synthesis by osteoblasts. This combination of activities 'uncouples' bone resorption and formation, thereby leading to a net loss of bone mass. The goal of this application is to elucidate the molecular mechanisms by which these mediators regulate bone remodeling, via effects on gene expression in bone cells.
In Aims 1 and 2, we will identify and evaluate the functional role of IL-1-induced resorption-related genes which are expressed in osteoblasts and osteoclasts. These genes will be identified by differential hybridization from a cDNA library derived from resorbing rat bone, and will be initially characterized by DNA sequencing. Both previously-described and novel genes will be obtained. Bone cells expressing these genes will be identified by in situ hybridization and/or immunolocalization. Functional relevance will be established by antisense deoxyoligonucleotide blockade of bone resorption in vitro.
In Aims 3 and 4, mechanisms of regulation of bone formation by cytokines will be studied at the molecular level, using osteocalcin as a model protein. The TNF-responsive element (TNF-RE) in the osteocalcin promoter will be mapped using deletion and oligonucleotide-directed mutants. The interaction of the TNF-RE with DNA-binding induced regulatory protein(s) will be characterized in gel retardation and DNase I footprint analyses. Regulatory protein(s) will be characterized. Homologs of the osteocalcin TNF-RE will be sought in other bone matrix protein promoters. Elucidation of the mechanisms involved in cytokine-induced uncoupling will permit the rational design of therapeutic agents which interfere with bone destruction in infectious and inflammatory diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute of Dental & Craniofacial Research (NIDCR)
Type
Research Project (R01)
Project #
2R01DE007378-08
Application #
3221039
Study Section
Oral Biology and Medicine Subcommittee 1 (OBM)
Project Start
1985-09-01
Project End
1996-08-31
Budget Start
1992-09-01
Budget End
1993-08-31
Support Year
8
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Forsyth Institute
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02142
Morse, L; Teng, Y D; Pham, L et al. (2008) Spinal cord injury causes rapid osteoclastic resorption and growth plate abnormalities in growing rats (SCI-induced bone loss in growing rats). Osteoporos Int 19:645-52
Battaglino, R A; Pham, L; Morse, L R et al. (2008) NHA-oc/NHA2: a mitochondrial cation-proton antiporter selectively expressed in osteoclasts. Bone 42:180-92
Pham, L; Purcell, P; Morse, L et al. (2007) Expression analysis of nha-oc/NHA2: a novel gene selectively expressed in osteoclasts. Gene Expr Patterns 7:846-51
Schulze-Spate, Ulrike; Battaglino, Ricardo; Fu, Jia et al. (2007) Brn3 transcription factors control terminal osteoclastogenesis. J Cell Biochem 102:1-12
Battaglino, R; Vokes, M; Schulze-Spate, U et al. (2007) Fluoxetine treatment increases trabecular bone formation in mice. J Cell Biochem 100:1387-94
Keles, Ahmet; Grunes, Brandon; Difuria, Catherine et al. (2007) Inhibition of tooth movement by osteoprotegerin vs. pamidronate under conditions of constant orthodontic force. Eur J Oral Sci 115:131-6
Okamatsu, Yoshimasa; Kim, David; Battaglino, Ricardo et al. (2004) MIP-1 gamma promotes receptor-activator-of-NF-kappa-B-ligand-induced osteoclast formation and survival. J Immunol 173:2084-90
Battaglino, R; Kim, D; Fu, J et al. (2002) c-myc is required for osteoclast differentiation. J Bone Miner Res 17:763-73
Deng, W; Stashenko, P; Chen, W et al. (2001) Characterization of mouse Atp6i gene, the gene promoter, and the gene expression. J Bone Miner Res 16:1136-46
Li, Y P; Chen, W; Liang, Y et al. (1999) Atp6i-deficient mice exhibit severe osteopetrosis due to loss of osteoclast-mediated extracellular acidification. Nat Genet 23:447-51

Showing the most recent 10 out of 27 publications